Lincoln Pharmaceuticals Limited (BOM:531633)
745.25
+28.05 (3.91%)
At close: May 26, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 15.19 billion as of May 27, 2026. Its market cap has increased by 33.65% in one year.
Market Cap
15.19B
Enterprise Value
12.87B
Revenue
6.52B
Ranking
n/a
PE Ratio
17.29
Stock Price
745.25
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 15.19B, an increase of 10,835.22%. That is a compound annual growth rate of 24.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 14.93B | 54.23% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unichem Laboratories | 24.89B |
| Morepen Laboratories | 24.09B |
| Kwality Pharmaceuticals | 22.45B |
| Amrutanjan Health Care | 16.16B |
| Venus Remedies | 15.55B |
| Syncom Formulations (India) | 14.68B |
| Fredun Pharmaceuticals | 13.22B |
| TTK Healthcare | 12.93B |